D-Amphetamine Boosts Language Learning Independent of its Cardiovascular and Motor Arousing Effects

D-Amphetamine (AMPH) was effective in a number of studies on motor and language recovery after stroke, but given safety concerns, its general use after stroke is still debated. Most stroke patients are excluded from treatment because of a significant risk of cardiovascular dysregulation. AMPH acts on multiple transmitter systems, and mainly the noradrenergic actions are related to the cardiovascular effects. If AMPH's cardiovascular and arousal effects were correlated with its plasticity-enhancing effects in humans, this would imply that desired and undesired effects are inevitably tied. If not, improved cerebral reorganization may not be mediated by AMPH's arousing effects and could be achieved with substances lacking the undesired cardiovascular effects. As a model for language recovery after stroke, we used a prospective, randomized, double-blind, placebo-controlled design and taught 40 healthy male subjects an artificial vocabulary of 50 concrete nouns over the course of five consecutive training days (high-frequency training). The associative learning principle involved higher co-occurrences of ‘correct’ picture-pseudoword pairings as compared to ‘incorrect’ pairings. Subjects received either AMPH (0.25 mg/kg) or placebo 90 min prior to training on each day. Novel word learning was significantly faster and better in the AMPH as compared to the placebo group. Increased learning success was maintained 1 month post-training. No correlation was found between training success and drug-induced increases in blood pressure, heart rate, or a facilitation of simple motor reaction time. Our data show that AMPH's plasticity-enhancing effect in humans is not related to its cardiovascular arousal. This suggests that the beneficial effects in stroke patients could also be obtained by less cardiovascular active drugs.

[1]  M. Devous,et al.  A Double-Blind, Placebo-Controlled Study of the Use of Amphetamine in the Treatment of Aphasia , 2001, Stroke.

[2]  R. Teasell,et al.  Rehabilitation of Aphasia: More Is Better , 2003, Topics in stroke rehabilitation.

[3]  Jonathan D. Cohen,et al.  Dopamine and the mechanisms of cognition: Part II. D-amphetamine effects in human subjects performing a selective attention task , 1998, Biological Psychiatry.

[4]  James N. Davis,et al.  Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients , 1988, Annals of neurology.

[5]  D. Walker-Batson,et al.  Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. , 1995, Stroke.

[6]  F. Müller,et al.  Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study , 2001, The Lancet.

[7]  C. Montigny,et al.  The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments , 1997, Brain Research Reviews.

[8]  D. M. Feeney,et al.  Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. , 1982, Science.

[9]  D. Hovda,et al.  Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat , 1984, Brain Research.

[10]  R. C. Oldfield The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[11]  K. Ressler,et al.  Role of norepinephrine in the pathophysiology and treatment of mood disorders , 1999, Biological Psychiatry.

[12]  Richard Coppola,et al.  Effects of Dextroamphetamine on Cognitive Performance and Cortical Activation , 2000, NeuroImage.

[13]  S. Wiebe Seizure Control as an Indicator of Therapeutic Usefulness , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[14]  K. Ressler,et al.  Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.

[15]  Paola Marangolo,et al.  Acquisition of New “Words” in Normal Subjects: A Suggestion for the Treatment of Anomia , 2001, Brain and Language.

[16]  Klaus P. Ebmeier,et al.  The effects of noradrenergic re-uptake inhibition on memory encoding in man , 2001, Psychopharmacology.

[17]  P. Groves,et al.  Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. , 1976, Annual review of psychology.

[18]  S. Hesse,et al.  No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study , 2003, Clinical rehabilitation.

[19]  J. Davis,et al.  Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat. , 1990, Restorative neurology and neuroscience.

[20]  Giuseppe Esposito,et al.  Dextroamphetamine Enhances “Neural Network-Specific” Physiological Signals: A Positron-Emission Tomography rCBF Study , 1996, The Journal of Neuroscience.

[21]  R. D'Hooge,et al.  Effect of amphetamine on long-term retention of verbal material , 1995, Psychopharmacology.

[22]  S. Haber,et al.  Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  D. Walker-Batson Use of Pharmacotherapy in the Treatment of Aphasia , 2000, Brain and Language.

[24]  B. Rockstroh,et al.  Constraint-Induced Therapy of Chronic Aphasia After Stroke , 2001, Stroke.

[25]  M. Deanna Pharmacological manipulation of human working memory , 2004 .

[26]  E. Ringelstein,et al.  Levodopa: Faster and better word learning in normal humans , 2004, Annals of neurology.

[27]  N. Wahlgren,et al.  Safety of Dexamphetamine in Acute Ischemic Stroke: A Randomized, Double-Blind, Controlled Dose-Escalation Trial , 2003, Stroke.

[28]  M. Viitanen,et al.  A Double-Blind Placebo-Controlled Study of the Effects of Amphetamine and Physiotherapy after Stroke , 2001, Cerebrovascular Diseases.

[29]  R. D'Hooge,et al.  Amphetamine enhances human-memory consolidation , 1993, Neuroscience Letters.

[30]  J. Kulisevsky,et al.  Role of Dopamine in Learning and Memory , 2000, Drugs & aging.

[31]  L. Goldstein Influence of common drugs and related factors on stroke outcome , 1997, Current opinion in neurology.

[32]  C. A. Morgan,et al.  Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans. , 2002, The American journal of psychiatry.

[33]  A. Basso,et al.  Aphasia Therapy or The importance of being earnest , 2001 .

[34]  L. Kalra,et al.  Racial inequity of access to carotid imaging. , 1999, Stroke.

[35]  DelainaWalker-Batson,et al.  Amphetamine Paired With Physical Therapy Accelerates Motor Recovery After Stroke , 1995 .

[36]  D. Barch Pharmacological manipulation of human working memory , 2003, Psychopharmacology.

[37]  D. M. Feeney,et al.  α-Noradrenergic agonists and antagonists affect recovery and maintenance of beam-walking ability after sensorimotor cortex ablation in the rat. , 1992, Restorative neurology and neuroscience.

[38]  D. M. Feeney,et al.  Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury , 1990, Pharmacology Biochemistry and Behavior.

[39]  D. Walker-Batson,et al.  A Double-Blind, Placebo-Controlled Study of the Use of Amphetamine in the Treatment of Aphasia , 2001, Stroke.

[40]  J. D. McGaugh,et al.  Role of the Basolateral Amygdala in Memory Consolidation , 2003, Annals of the New York Academy of Sciences.

[41]  L. Goldstein,et al.  Amphetamine-facilitated poststroke recovery. , 1999, Stroke.

[42]  L. Goldstein Amphetamines and related drugs in motor recovery after stroke. , 2003, Physical medicine and rehabilitation clinics of North America.

[43]  S. Eksborg,et al.  Drugs for Stroke Recovery , 2004, Drugs & aging.

[44]  Caterina Breitenstein,et al.  Development and validation of a language learning model for behavioral and functional-imaging studies , 2002, Journal of Neuroscience Methods.

[45]  D. Gladstone,et al.  Enhancing Recovery after Stroke with Noradrenergic Pharmacotherapy: A New Frontier? , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[46]  Sylvain Houle,et al.  Oral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET , 2004, Synapse.

[47]  R. Teasell,et al.  Intensity of Aphasia Therapy, Impact on Recovery , 2003, Stroke.

[48]  J. Nutt,et al.  Pharmacokinetics of levodopa. , 1984, Clinical neuropharmacology.

[49]  Paul E Kinahan,et al.  PET Measures of Amphetamine-Induced Dopamine Release in Ventral versus Dorsal Striatum , 1999, Neuropsychopharmacology.

[50]  Robert S. Pinals,et al.  A double‐blind, placebo‐controlled trial , 1986 .

[51]  Robert B. Innis,et al.  Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naı̈ve healthy volunteers: results from a large cohort , 2003, European Neuropsychopharmacology.

[52]  D. Hovda,et al.  Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation , 1985, Brain Research.

[53]  Carl-Walter Kohlmann,et al.  Untersuchungen mit einer deutschen Version der "Positive and Negative Affect Schedule" (PANAS). , 1996 .

[54]  N. Schneiderman,et al.  Amphetamine promotes recovery from sensory-motor integration deficit after thrombotic infarction of the primary somatosensory rat cortex. , 1991, Stroke.

[55]  R. R. Robey The Efficacy of Treatment for Aphasic Persons: A Meta-analysis , 1994, Brain and Language.

[56]  C. Breitenstein,et al.  Spracherwerb und statistisches Lernen , 2003, Der Nervenarzt.

[57]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[58]  M. Egan,et al.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine , 2003, Proceedings of the National Academy of Sciences of the United States of America.